Acorda Therapeutics, Inc. Finite-Lived Intangible Assets, Net
Acorda Therapeutics, Inc. had Finite-Lived Intangible Assets, Net of $22.99 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2024-04-01
- 2023-12-31: Finite-Lived Intangible Assets, Net $22.99M.
- 2022-12-31: Finite-Lived Intangible Assets, Net $305.09M.
- 2021-12-31: Finite-Lived Intangible Assets, Net $335.98M.
- 2020-12-31: Finite-Lived Intangible Assets, Net $366.98M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2023-12-31 | $22.99M 10-K · filed 2024-04-01 |
| 2022-12-31 | $305.09M 10-K · filed 2024-04-01 |
| 2021-12-31 | $335.98M 10-K · filed 2022-03-18 |
| 2020-12-31 | $366.98M 10-K · filed 2021-03-16 |
| 2019-12-31 | $398.12M 10-K · filed 2020-02-28 |
| 2018-12-31 | $423.57M 10-K · filed 2019-02-27 |
| 2017-12-31 | $2.84M 10-K/A · filed 2018-03-09 |
| 2016-12-31 | $64.49M 10-K · filed 2017-02-27 |
| 2016-09-30 | $66.93M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $69.37M 10-Q · filed 2016-08-04 |
| 2014-09-30 | $16.86M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $17.28M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $17.96M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $17.46M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $17.59M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $9.88M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $9.45M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $9.32M 10-K · filed 2014-03-03 |
| 2011-12-31 | $8.77M 10-K · filed 2013-02-28 |